CDER
This article was originally published in The Tan Sheet
Executive Summary
OTC approvals, new labeling reg, June OTC public meeting highlighted as achievements in center's 2000 "Report to the Nation," posted on Web site April 27. Summarizing accomplishments from last year, report notes approval of eight new OTC drugs, three new OTC uses. "We are open to the possibility of having more and different kinds of OTC medicines available to consumers," center states. Report covers drug review, drug safety and quality, international activities and communication
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning